Work

A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma.

Year: 1999

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: M L Grossbard, P S Multani, A S Freedman, S O'Day, J G Gribben, C Rhuda, D Neuberg, L M Nadler

Institutions: Massachusetts General Hospital, Harvard University, Dana-Farber Cancer Institute

Language: English

Topic: Toxin Mechanisms and Immunotoxins

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

Awards: GERMINAL CENTER INTERACTIONS OF NORMAL/MALIGNANT B CELLS, CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM, Development of Novel Therapeutic Strategies in Human Leukemias

OpenAlex ID: W1862030292

FWCI: 1.282

Cites: 23

Cited by: 49

Related to: 10